Cited by 194Viral Infections and Immunology ResearchCardiovascular Effects of ExerciseCardiomyopathy and Myosin Studies

Altered Desmosomal Proteins in Granulomatous Myocarditis and Potential Pathogenic Links to Arrhythmogenic Right Ventricular Cardiomyopathy

Open access
Asimaki, Angeliki, Tandri, Harikrishna, Duffy, Elizabeth R., Winterfield, Jeffrey R., Mackey-Bojack, Shannon, Picken, Maria M., Cooper, Leslie T., Wilber, David J. +11 more·2011·Circulation: Arrhythmia and Electrophysiology

Abstract

Background—: Immunoreactive signal for the desmosomal protein plakoglobin (γ-catenin) is reduced at cardiac intercalated disks in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), a highly arrhythmogenic condition caused by mutations in genes encoding desmosomal proteins. Previously, we observed a false-positive case in which plakoglobin signal was reduced in a patient initially believed to have ARVC but who actually had cardiac sarcoidosis. Sarcoidosis can masquerade clinically as ARVC but has not been previously associated with altered desmosomal proteins. Methods and Results—: We observed marked reduction in immunoreactive signal for plakoglobin at cardiac myocyte junctions in patients with sarcoidosis and giant cell myocarditis, both highly arrhythmogenic forms of myocarditis associated with granulomatous inflammation. In contrast, plakoglobin signal was not depressed in lymphocytic (nongranulomatous) myocarditis. To determine whether cytokines might promote dislocation of plakoglobin from desmosomes, we incubated cultures of neonatal rat ventricular myocytes with selected inflammatory mediators. Brief exposure to low concentrations of interleukin (IL)-17, tumor necrosis factor-α (TNF-α), and IL-6 (cytokines implicated in granulomatous myocarditis) caused translocation of plakoglobin from cell-cell junctions to intracellular sites, whereas other potent cytokines implicated in nongranulomatous myocarditis had no effect, even at much higher concentrations. We also observed myocardial expression of IL-17 and TNF-α and elevated levels of serum inflammatory mediators, including IL-6R, IL-8, monocyte chemoattractant protein 1, and macrophage inflammatory protein 1β, in patients with ARVC (all P <0.0001 compared with controls). Conclusions—: The results suggest novel disease mechanisms involving desmosomal proteins in granulomatous myocarditis and implicate cytokines, perhaps derived in part from the myocardium, in disruption of desmosomal proteins and arrhythmogenesis in ARVC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circep.111.964890

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elevated levels of circulating and myocardial inflammatory cytokines and chemokines from DGV-linked ACM subjects have been observed across disease phases and phenotypes.

    “Prior works have shown elevated levels of circulating [22] and myocardial inflammatory cytokines and chemokines from DGV-linked ACM subjects [11,23] that have been observed across disease phases and phenotypes”

    From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [22]

    The Results section, “Myocardial expression of cytokines in ARVC” (page unavailable), reports increased myocardial IL-17 and TNFα signals in ARVC cases, including five with documented desmosomal gene mutations. It does not establish that these elevations occur across disease phases or phenotypes. The paper also reports elevated circulating inflammatory mediators, but the citing sentence assigns the circulating finding to a different citation [22]. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 45

  1. [1]Basso C Corrado D Marcus FI Nava A Thiene G Arrhythmogenic right ventricular cardiomyopathy Lancet 2009 373 1289 1300 19362677
  2. [2]Asimaki A Tandri H Huang H Halushka MK Gautam S Basso C Thiene G Tsatsopoulou A Protonotarios N McKenna WJ Calkins H Saffitz JE A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy N Engl J Med 2009 360 1075 1084 19279339
  3. [3]Soejima K Yada H The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities J Cardiovasc Electrophysiol 2009 20 578 583 19175448
  4. [4]Vasaiwala SC Finn C Delpriore J Leya F Gagermeier J Akar JG Santucci P Dajani K Bova D Picken MM Basso C Marcus F Wilber DJ Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia J Cardiovasc Electrophysiol 2009 20 473 476 19017339
  5. [5]Ladyjanskaia GA Basso C Hobbelink MG Kirkels JH Lahpor JR Cramer MJ Thiene G Hauer RN Oosterhout MFV Sarcoid myocarditis with ventricular tachycardia mimicking ARVD/C J Cardiovasc Electrophysiol 2010 21 94 98 19473301
  6. [6]Granér M Lommi J Kupari M Räisänen-Sokolowski A Toivonen L Multiple forms of sustained monomorphic ventricular tachycardia as common presentation in giant-cell myocarditis Heart 2007 93 119 121 17170352 PMC1861355
  7. [7]Blauwet LA Cooper LT Antimicrobial agents for myocarditis: target the pathway, not the pathogen Heart 2010 96 494 495 19617212 PMC5813691
  8. [8]Nash CL Panaccione R Sutherland LR Meddings JB Giant cell myocarditis, in a patient with Crohn’s disease, treated with etanercept - a tumour necrosis factor-alpha antagonist Can J Gastroenterol 2001 15 607 611 11573104
  9. [9]Liu W Feng W Wang F Li W Gao C Zhou B Ma M Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease Exp Mol Pathol 2008 84 213 217 18417124
  10. [10]Ahuja SS Estrada CA Lindsey ML Crosstalk between cytotoxic T-lymphocyte associated antigen-4 and interleukin-12 in cytotoxic T-lymphocyte-mediated myocarditis: adding another link to the chain Circ Res 2007 101 218 220 17673678
  11. [11]Fairweather D Frisancho-Kiss S Yusung SA Barrett MA Davis SE Gatewood SJ Njoku DB Rose NR Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart Am J Pathol 2004 165 1883 1894 15579433 PMC1618717
  12. [12]Saffitz JE Green KG Kraft WJ Schechtman KB Yamada KA Effects of diminished expression of connexin43 on gap junction number and size in ventricular myocardium Am J Physiol (Heart Circ Physiol) 2000 278 H1662 H1670 10775147
  13. [13]Godin-Ethier J Pelletier S Hanafi LA Gannon PO Forget MA Routy JP Boulassel MR Krzemien U Tanguay S Lattouf JB Arbour N Lapointe R Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance J Immunol 2009 183 7752 7760 19933867
  14. [14]MacKenzie CR González RG Kniep E Roch S Däubener W Cytokine mediated regulation of interferon-gamma-induced IDO activation Adv Exp Med Biol 1999 467 533 539 10721097
  15. [15]Singer CF Kronsteiner N Hudelist G Marton E Walter I Kubista M Czerwenka K Schreiber M Seifert M Kubista E Interleukin-1 system and sex steroid receptor expression in human breast cancer: interleukin 1alpha protein secretion is correlated with malignant phenotype Clin Cancer Res 2003 9 4877 4883 14581361
  16. [16]Pimentel RC Yamada KA Kleber AG Saffitz JE Autocrine regulation of myocyte Cx43 expression by VEGF Circ Res 2002 90 671 677 11934834
  17. [17]Yamada K Green KG Samarel AM Saffitz JE Distinct pathways regulate expression of cardiac electrical and mechanical junction proteins in response to stretch Circ Res 2005 97 346 353 16037569
  18. [18]Asimaki A Syrris P Wichter T Matthias P Saffitz JE McKenna WJ A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy Am J Hum Genet 2007 81 964 973 17924338 PMC2265660
  19. [19]Marcus FI McKenna WJ Sherrill D Basso C Bauce B Bluemke DA Calkins H Corrado DA Cox MG Daubert J Fontaine G Gear K Hauer RN Nava A Picard MH Protonotarios N Saffitz JE Sanborn DM Steinberg JS Tandri HM Thiene G Towbin JA Tsatsopoulou A Wichter T Zareba W Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D); proposed modification of the Task Force criteria Circulation 2010 121 1533 1541 20172911 PMC2860804
  20. [20]Knight PR Sreekumar A Siddiqui J Laxman B Copeland S Chinnaiyan A Remick DG Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis Shock 2004 21 26 30 14676680
  21. [21]Rosenstein ED Zucker MJ Kramer N Giant cell myocarditis: most fatal of autoimmune diseases Semin Arthritis Rheum 2000 30 1 16 10966208
  22. [22]Aretz HT Billingham ME Edwards WD Factor SM Fallon JT Fenoglio JJ Olsen EG Schoen FJ Myocarditis. A histopathologic definition and classification Am J Cardiovasc Pathol 1987 1 3 14 3455232
  23. [23]Eiken HG Oie E Damas JK Yndestad A Bjerkeli V Aass H Simonsen S Geiran OR Tonnessen T Christensen G Froland SS Gullestad L Attramada H Aukrust P Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein130 in end-stage human heart failure Eur J Clin Invest 2001 31 389 397 11380590
  24. [24]Podewski EK Hilfiker-Kleiner D Hilfiker A Morawietz H Lichtenberg A Wollert KC Drexler H Alterations in Janus kinase (JAK) - signal transducers and activations of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy Circulation 2003 107 789 802 12591746
  25. [25]Gwechenberger M Hülsmann M Berger R Graf S Springer C Stanek B Pacher R Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure J Heart Lung Transplant 2004 23 839 844 15261178
  26. [26]Basso C Thiene G Corrado D Angelini A Nava A Valente M Arrhythmogenic right ventricular cardiomyopathy: Dysplasia, dystrophy or myocarditis? Circulation 1996 94 983 991 8790036
  27. [27]Irwin MW Mak S Mann DL Qu R Penninger JM Yan A Dawood F Wen WH Shou Z Liu P Tissue expression and immunolocalization of tumor necrosis factor-alpha in post-infarction dysfunctional myocardium Circulation 1999 99 1492 1498 10086975
  28. [28]Nian M Lee P Khaper N Liu P Inflammatory cytokines and postmyocardial infarction remodeling Circ Res 2004 94 1543 1553 15217919
  29. [29]Agrawal RA Koyani CN Singh R Molecular targets and regulators of cardiac hypertrophy Pharmacol Res 2010 61 269 280 19969085
  30. [30]Deswal A Petersen NJ Feldman AM Young JB White BG Mann DL Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone Trial (VEST) Circulation 2001 103 2055 2059 11319194
  31. [31]Bradham WS Boskurt B Gunasinghe H Mann D Spinale FG Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a clinical perspective Cardiovasc Res 2002 53 822 830 11922892
  32. [32]Dibbs Z Thornby J White BG Mann DL Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: Implications for clinical trials J Am Coll Cardiol 1999 33 1935 1942 10362196
  33. [33]Amagai M Autoimmune and infectious skin diseases that target desmogleins Proc Jpn Acad Ser B Phys Biol Sci 2010 86 524 537 PMC3108298 20467217
  34. [34]Schulzke JD Ploeger S Amasheh M Fromm A Zeissig S Troeger H Richter J Bojarski C Schumann M Fromm M Epithelial tight junctions in intestinal inflammation Ann NY Acad Sci 2009 1165 294 300 19538319
  35. [35]Schmidt A Koch PJ Desmosomes: just cell adhesion or is there more? Cell Adh Migr 2007 1 28 32 19262094 PMC2633677
  36. [36]Kaplan SR Gard JJ Protonotarios N Tsatsopoulou A Spiliopoulou C Anastasakis A Squarcioni CP McKenna WJ Thiene G Basso C Brousse N Fontaine G Saffitz JE Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease) Heart Rhythm 2004 1 3 11 15851108
  37. [37]Fidler LM Wilson GJ Liu F Cui X Scherer SW Taylor GP Hamilton RM Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations J Cell Mol Med 2009 13 4219 4228 18662195 PMC4496128
  38. [38]Saffitz JE Hames KY Kanno S Remodeling of gap junctions in ischemic and nonischemic forms of heart disease J Membr Biol 2007 218 65 71 17585361
  39. [39]Severs NJ Dupont E Thomas N Kaba R Rothery S Jain R Sharpey K Fry CH Alterations in cardiac connexin expression in cardiomyopathies Adv Cardiol 2006 42 228 242 16646594
  40. [40]Li J Solus J Chen Q Rho YH Milne G Stein CM Darbar D Role of inflammation and oxidative stress in atrial fibrillation Heart Rhythm 2010 7 438 444 20153266 PMC2843774
  41. [41]Torre-Amione G Kapadia S Lee J Durant JB Bies RD Young JB Mann DL Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart Circulation 1996 93 704 711 8640999
  42. [42]Symons JA Young PR Duff GW Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist Proc Natl Acad Sci USA 1995 92 1714 1718 7878046 PMC42590
  43. [43]Campian ME Verberne HJ Hardziyenka M de Groot EAA van Moerkerken AF van Eck-Smit BLF Tan HL Assessment of inflammation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia Eur J Nucl Med Mol Imaging 2010 37 2079 2085 20603720 PMC2948173
  44. [44]Fuse K Kodama M Okura Y Ito M Aoki Y Hirono S Kato K Hanawa H Aizawa Y Levels of serum interleukin-10 reflect disease activity in patients with cardiac sarcoidosis Jpn Circ J 2000 64 755 759 11059615
  45. [45]Matsumori A Yamada T Suzuki H Matoba Y Sasayama S Increaed circulting cytokines in patients with myocarditis and cardiomyopathy Br Heart J 1994 72 561 566 7857740 PMC1025643

Cited by

Sorted by citations

Authors
Asimaki, A., Tandri, H., Duffy, E. R., Winterfield, J. R., Mackey-Bojack, S., Picken, M. M., Cooper, L. T., Wilber, D. J., Marcus, F. I., Basso, C., Thiene, G., Tsatsopoulou, A., Protonotarios, N., Stevenson, W. G., McKenna, W. J., Gautam, S., Remick, D. G., Calkins, H., & Saffitz, J. E.
Affiliations
  • Boston University (US)
  • From the Department of Pathology (A.A., J.E.S.) and Department of Medicine (S.G.), Beth Israel Deaconess Medical Center and Harvard Medical School, the Department of Medicine (J.R.W., W.G.S.), Brigham and Women's Hospital and Harvard Medical School, and Department of Pathology, Boston University Medical Center (E.R.D., D.G.R.), Boston, MA; Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD (H.T., H.C.); Jesse E. Edwards Registry of Cardiovascular Diseases, St Paul, MN (S.M.-B....
Venue
Circulation: Arrhythmia and Electrophysiology
Published
2011-10
Volume
4
Issue
5
Pages
743-752
ISSN
  • 1941-3084 (ISSN-L)
  • 1941-3149
OpenAlex
W2127460971
Cited by
194
References
0
Citations by year
2026: 8 · 2025: 10 · 2024: 8 · 2023: 21 · 2022: 9 · 2021: 22 · 2020: 24 · 2019: 9 · 2018: 8 · 2017: 10 · 2016: 11 · 2015: 14 · 2014: 12 · 2013: 14 · 2012: 12
FWCI
8.80
Type
journal article
Language
en
Open access
Locations
  • Circulation Arrhythmia and Electrophysiology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
  • Brigham and Women's Hospital
  • National Heart, Lung, and Blood Institute (K23HL093350, RC1HL100110, HL102361, R01HL102361)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords
arrhythmogenic right ventricular cardiomyopathy, plakoglobin, desmosomal proteins, granulomatous myocarditis, sarcoidosis, giant cell myocarditis, cytokines, IL-17, TNF-α, interleukin-6, intercalated discs, arrhythmogenesis, inflammatory mediators
MeSH terms
Adolescent, Adult, Aged, Animals, Arrhythmias, Cardiac, Autopsy, Biopsy, Cells, Cultured, Child, Desmosomes, Female, Humans, Intercellular Junctions, Male, Middle Aged, Cardiomyopathies, Myocarditis, Sarcoidosis, Tumor Necrosis Factor-alpha, Signal Transduction, Interleukin-6, Case-Control Studies, Interleukin-8, Rats, Wistar, Ventricular Dysfunction, Right, Chemokine CCL2, Interleukin-17, Models, Animal, Myocytes, Cardiac, gamma Catenin, Rats, Chemokine CCL4, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review